Metabolic syndrome in chronic obstructive pulmonary disease

Simple item page
dc.contributor.authorPasha, M. D. Majeeden_US
dc.contributor.authorSalimath, Shivalingaswamyen_US
dc.contributor.authorK. N., Mohan Raoen_US
dc.contributor.authorH. J., Gayathri Devien_US
dc.contributor.authorAneja, Anshumen_US
dc.contributor.authorPadmaja, Mantha Satyaen_US
dc.contributor.authorHalappa, Sujithen_US
dc.date.accessioned2020-04-09T07:40:03Z
dc.date.available2020-04-09T07:40:03Z
dc.date.issued2018-05
dc.description.abstractBackground: COPD (Chronic obstructive pulmonary disease) is considered as a systemic disease due to associated systemic inflammation which can manifest as metabolic syndrome or its component illnesses. This study was undertaken to determine the proportion of metabolic syndrome in patients with COPD.Methods: 51 patients with COPD were compared with equal number of age and gender matched controls. GOLD (Global Initiative for Chronic Obstructive Lung Disease) criteria were used for diagnosing COPD. Metabolic Syndrome (MS) was diagnosed based on modified NCEP:ATP III criteria (National cholesterol education Program Adult Treatment Panel III). Subjects were evaluated for hypertension, WC, FBS, and serum triglycerides and serum HDL (High-density lipoprotein) to diagnose MS.Results: Metabolic syndrome was diagnosed in 16 (31.4%) patients with COPD and in 8 (15.7%) controls. The proportion of individual parameters of MS in cases and controls was as follows: DM in 19 (37.3%) cases and 13 (25.5%) controls, hypertension in 21(41.2%) cases and 9 (17.6%) controls, low serum HDL in 31 (60.7%) cases and 22 (43.1%) controls increased WC in 14 (27.5%) cases and 7 (13.7%) controls and elevated serum TG in 12 (23.5%) cases and an equal number of controls.Conclusions: Metabolic syndrome and its parameters are more prevalent in COPD patients. Early detection and treatment of MS in COPD patients can prevent development of complications due to the combined effects of both diseasesen_US
dc.identifier.affiliationsDepartment of Respiratory Medicine, Rajrajeshwari Medical College and Hospital, Bangalore, Karnataka, Indiaen_US
dc.identifier.affiliationsDepartment of Respiratory Medicine, MS Ramiah Medical College, Bangalore, Karnataka, Indiaen_US
dc.identifier.affiliationsConsultant Pulmonologist, Aero Health Care, Gurgaon, New Delhi, Indiaen_US
dc.identifier.affiliationsDepartment of Respiratory Medicine, MS Ramiah Medical College, Bangalore, Karnataka, Indiaen_US
dc.identifier.affiliationsDepartment of Respiratory Medicine, Subbaiah Institute of Medical Sciences, Shimoga, Karnataka, Indiaen_US
dc.identifier.citationPasha M. D. Majeed, Salimath Shivalingaswamy, K. N. Mohan Rao, H. J. Gayathri Devi, Aneja Anshum, Padmaja Mantha Satya, Halappa Sujith. Metabolic syndrome in chronic obstructive pulmonary disease. International Journal of Advances in Medicine. 2018 May; 5(3): 597-603en_US
dc.identifier.issn2349-3925
dc.identifier.issn2349-3933
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/193985
dc.languageenen_US
dc.publisherMedip Academyen_US
dc.relation.issuenumber3en_US
dc.relation.volume5en_US
dc.source.urihttps://dx.doi.org/10.18203/2349-3933.ijam20182109en_US
dc.subjectBody Mass Indexen_US
dc.subjectChemo attractant proteinen_US
dc.subjectCOPDen_US
dc.subjectForced expiratory volume in one seconden_US
dc.subjectForced vital capacityen_US
dc.subjectGOLDen_US
dc.subjectHDLen_US
dc.subjectMSen_US
dc.subjectNCEP: ATP IIIen_US
dc.titleMetabolic syndrome in chronic obstructive pulmonary diseaseen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijam2018v5n3p597.pdf
Size:
205.27 KB
Format:
Adobe Portable Document Format
Download
Collections
International Journal of Advances in Medicine